ANTI-IDIOTYPIC ANTIBODIES WHICH NEUTRALISE THE INHIBITORY ACTIVITY OF AN INHIBITORY ANTIBODY DIRECTED AGAINST THE C1 DOMAIN OF FACTOR VIII

摘要

The present invention relates to an anti-idiotypic monoclonal antibody directed against a Factor VIII-inhibiting antibody which binds to the C1 domain of Factor VIII, and also relates to a cell line producing this anti-idiotypic monoclonal antibody, to the use of this anti-idiotypic monoclonal antibody as a medicament, and more particularly to the use thereof for the manufacture of a medicament for the treatment of haemophilia A.